A phase I/II study of panitumumab combined with TAS-102 in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC) refractory to standard chemotherapy: APOLLON study

K. Yamazaki; H. Yasui; K. Yamaguchi; Y. Kagawa; Y. Kuboki; T. Yoshino; M. Gamoh; Y. Komatsu; H. Satake; M. Goto; H. Tanioka; E. Oki; M. Kotaka; A. Makiyama; T. Denda; J. Soeda; K. Shibya; M. Iwata; K. Oba; T. Kato

doi:10.1093/annonc/mdy151.252

A phase I/II study of panitumumab combined with TAS-102 in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC) refractory to standard chemotherapy: APOLLON study

K. Yamazaki, H. Yasui, K. Yamaguchi, Y. Kagawa, Y. Kuboki, T. Yoshino, M. Gamoh, Y. Komatsu, H. Satake, M. Goto, H. Tanioka, E. Oki, M. Kotaka, A. Makiyama, T. Denda, J. Soeda, K. Shibya, M. Iwata, K. Oba, T. Kato

Gastrointestinal Surgery (2)

Research output: Contribution to journal › Article › peer-review

224 Citations (Scopus)

Original language	English
Pages (from-to)	v71
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy151.252
Publication status	Published - Jun 1 2018

All Science Journal Classification (ASJC) codes

Hematology
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdy151.252

Cite this

Yamazaki, K., Yasui, H., Yamaguchi, K., Kagawa, Y., Kuboki, Y., Yoshino, T., Gamoh, M., Komatsu, Y., Satake, H., Goto, M., Tanioka, H., Oki, E., Kotaka, M., Makiyama, A., Denda, T., Soeda, J., Shibya, K., Iwata, M., Oba, K., & Kato, T. (2018). A phase I/II study of panitumumab combined with TAS-102 in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC) refractory to standard chemotherapy: APOLLON study. Annals of oncology : official journal of the European Society for Medical Oncology, 29, v71. https://doi.org/10.1093/annonc/mdy151.252

A phase I/II study of panitumumab combined with TAS-102 in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC) refractory to standard chemotherapy: APOLLON study. / Yamazaki, K.; Yasui, H.; Yamaguchi, K. et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.06.2018, p. v71.

Research output: Contribution to journal › Article › peer-review

Yamazaki, K, Yasui, H, Yamaguchi, K, Kagawa, Y, Kuboki, Y, Yoshino, T, Gamoh, M, Komatsu, Y, Satake, H, Goto, M, Tanioka, H, Oki, E, Kotaka, M, Makiyama, A, Denda, T, Soeda, J, Shibya, K, Iwata, M, Oba, K & Kato, T 2018, 'A phase I/II study of panitumumab combined with TAS-102 in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC) refractory to standard chemotherapy: APOLLON study', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. v71. https://doi.org/10.1093/annonc/mdy151.252

Yamazaki K, Yasui H, Yamaguchi K, Kagawa Y, Kuboki Y, Yoshino T et al. A phase I/II study of panitumumab combined with TAS-102 in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC) refractory to standard chemotherapy: APOLLON study. Annals of oncology : official journal of the European Society for Medical Oncology. 2018 Jun 1;29:v71. doi: 10.1093/annonc/mdy151.252

@article{239644bb492244599db753f29c551e49,

title = "A phase I/II study of panitumumab combined with TAS-102 in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC) refractory to standard chemotherapy: APOLLON study",

author = "K. Yamazaki and H. Yasui and K. Yamaguchi and Y. Kagawa and Y. Kuboki and T. Yoshino and M. Gamoh and Y. Komatsu and H. Satake and M. Goto and H. Tanioka and E. Oki and M. Kotaka and A. Makiyama and T. Denda and J. Soeda and K. Shibya and M. Iwata and K. Oba and T. Kato",

year = "2018",

month = jun,

day = "1",

doi = "10.1093/annonc/mdy151.252",

language = "English",

volume = "29",

pages = "v71",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - A phase I/II study of panitumumab combined with TAS-102 in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC) refractory to standard chemotherapy

T2 - APOLLON study

AU - Yamazaki, K.

AU - Yasui, H.

AU - Yamaguchi, K.

AU - Kagawa, Y.

AU - Kuboki, Y.

AU - Yoshino, T.

AU - Gamoh, M.

AU - Komatsu, Y.

AU - Satake, H.

AU - Goto, M.

AU - Tanioka, H.

AU - Oki, E.

AU - Kotaka, M.

AU - Makiyama, A.

AU - Denda, T.

AU - Soeda, J.

AU - Shibya, K.

AU - Iwata, M.

AU - Oba, K.

AU - Kato, T.

PY - 2018/6/1

Y1 - 2018/6/1

UR - http://www.scopus.com/inward/record.url?scp=85081590027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081590027&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy151.252

DO - 10.1093/annonc/mdy151.252

M3 - Article

C2 - 32177235

SN - 0923-7534

VL - 29

SP - v71

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

A phase I/II study of panitumumab combined with TAS-102 in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC) refractory to standard chemotherapy: APOLLON study

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this